2020-11-12T13:24:54-06:00 2019-12-31 861065772 DELOITTE TAX LLP 925 FOURTH AVENUE SUITE 3300 SEATTLE WA 981041126 990 2019-01-01 821808476 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE BILL 8577022108 ONE KENDALL SQ BLDG 600 NO 6-301 CAMBRIDGE MA 02139 MARY THISTLE TREASURER 8577022108 2020-11-03 1 JOLENE G COX P00235481 2067167000 24.19.11.164 2020-11-11 16:40:33 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 CD241C3169EB32752A76399138F7558C8E612C64 2019 2021-01-29 14:40:06Z PENNY M HEATON ONE KENDALL SQ BLDG 600 NO 6-301 CAMBRIDGE MA 02139 9807864 0 X WWW.GATESMRI.ORG X 2017 WA THE GATES MRI ACTIVELY AND CONTINUOUSLY ENGAGES DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-INCOME COUNTRIES. 5 0 76 0 0 0 9622298 9254862 0 0 200186 545619 0 7383 9822484 9807864 0 0 0 0 14113780 24217965 0 0 0 8259858 17009587 22373638 41227552 -12551154 -31419688 248840285 219318998 1720195 3618596 247120090 215700402 X THE GATES MRI ACTIVELY AND CONTINUOUSLY ENGAGES DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-INCOME COUNTRIES. 0 0 32648612 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ("GATES MRI") IS ALIGNED WITH THE PURPOSE OF THE BILL & MELINDA GATES FOUNDATION AND GUIDED BY THE VISION THAT EVERY PERSON DESERVES THE OPPORTUNITY TO LEAD A HEALTHY AND PRODUCTIVE LIFE. THE GATES MRI ACTIVELY AND CONTINUOUSLY ENGAGES DIRECTLY IN MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-AND MIDDLE-INCOME COUNTRIES. THE GATES MRI WORKS TO CAPITALIZE ON INNOVATIONS IN MEDICAL RESEARCH, EMPLOYING RIGOROUS APPROACHES TO RESEARCH AND DEVELOPMENT, TO IDENTIFY PRODUCT CANDIDATES FOR DRUG THERAPIES, VACCINES, MONOCLONAL ANTIBODIES THAT ADDRESS DISEASES DISPROPORTIONATELY BURDENING THE WORLD'S POOREST PEOPLE. THE GATES MRI'S GOALS ARE TO ERADICATE MALARIA, ACCELERATE THE END OF THE TUBERCULOSIS EPIDEMIC, END DIARRHEAL DEATHS IN CHILDREN AND FIGHT SERIOUS DISORDERS AFFECTING MATERNAL AND NEWBORN CHILD HEALTH. 32648612 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 29 0 1 76 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 0 1 0 0 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 WA MA X X JENNIFER DEGER 2067093100 500 FIFTH AVENUE N SEATTLE WA 98109 SUSAN DESMOND-HELLMANN DIRECTOR 2.00 40.00 X 0 1461692 67612 TREVOR MUNDEL DIRECTOR, BOARD CHAIR 3.00 40.00 X 0 1089701 78684 HELENE MADONICK DIRECTOR 2.00 40.00 X 0 733051 76323 EMILIO EMINI DIRECTOR 2.00 40.00 X 0 541573 65986 ANDREW FARNUM DIRECTOR 2.00 40.00 X 0 416794 56530 PENNY HEATON CHIEF EXECUTIVE OFFICER 40.00 0.00 X 773468 0 65887 HELEN BOUDREAU END 812019 SECRETARY & TREASURER 40.00 0.00 X 484905 0 60253 MARY THISTLE START 812019 TREASURER 40.00 0.00 X 454784 0 65568 SALLY JENNINGS START 812019 SECRETARY 40.00 0.00 X 413243 0 78097 DAVID KAUFMAN HEAD OF TRANSLATIONAL DEVELOPMENT 40.00 0.00 X 566324 0 76335 JORG THOMMES HEAD OF CHEM, MFG & CONTROLS 40.00 0.00 X 446244 0 76224 DINA BERDIEVA HEAD OF PROJ. MGMT. & CLIN 40.00 0.00 X 428665 0 83842 JARED SILVERMAN HEAD OF TRANSLATIONAL DISCOVERY 40.00 0.00 X 415128 0 78557 TARYN ROGALSKI-SALTER HEAD OF REGULATORY AFFAIRS 40.00 0.00 X 468311 0 68207 JEFFREY BARRET HEAD OF QUANT. SCIENCES 40.00 0.00 X 456323 0 76224 ALEXANDER SCHMIDT CLINICAL DEVELOPMENT LEADER 40.00 0.00 X 430566 0 78692 RUSSELL WEINER BIOMARKER ASSAY DEVELOPMENT LEADER 40.00 0.00 X 438231 0 66387 DEBRA WEISS HEAD OF QUALITY ASSURANCE 40.00 0.00 X 427306 0 69484 6203498 4242811 1288892 62 0 1 0 MMS HOLDINGS INC 880 COMMERCE BLVD CANTON MI 48187 CLINICAL DATA MGMT SERVICES 1047762 INTERNATIONAL AIDS VACCINE INITIATIVE 125 BROAD ST 9TH FL NEW YORK NY 10004 BIOREPOSITORY 950407 INSOURCE SERVICES INC 148 LINDEN ST WELLESLEY MA 02482 ACCOUNTING & IT SERVICES 846064 SYNPHABASE AG GUETERSTRASSE 82 PRATTELN SZ 4133 CONTRACT MFG ORG (CMO) 826014 IQVIA RDS INC 4820 EMPEROR BLVD DURHAM NC 27703 CLINICAL RESEARCH ORG 782935 21 9212442 42420 9254862 545619 545619 7383 7383 7383 9807864 0 0 553002 X 4567523 2662659 1904864 14002264 11093938 2908326 1876006 1486352 389654 2855449 2594766 260683 916723 692009 224714 1393169 1331578 61591 381432 381432 10031560 8947381 1084179 75075 75075 152719 83679 69040 640442 480344 160098 2275295 1654077 621218 1474709 1251542 223167 93698 69479 24219 6522 6522 41085 19440 21645 RECRUITING 219694 166038 53656 FURNITURE & EQUIPMENT 132268 36187 96081 DUES & SUBSCRIPTIONS 69977 61451 8526 OTHER TAXES & FEES 132 665 -533 21810 17027 4783 41227552 32648612 8578940 0 15406853 30229648 232900096 184053647 46088 44854 2098774 2393341 7032 5609 2386309 482873 504532 248840285 219318998 1720195 3618596 1720195 3618596 X 247120090 215700402 247120090 215700402 248840285 219318998 -31419688 0 X 0 1 X 1 0 X UNIVERSITY OF WASHINGTON SEATTLE WA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1938516 1938516 454825 7032 447793 2386309 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES CONDUCT MEDICAL RESEARCH, IDENTIFY MEDICAL RESEARCH PARTNERS 22326 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CONDUCT MEDICAL RESEARCH, IDENTIFY MEDICAL RESEARCH PARTNERS 3147127 NORTH AMERICA 0 0 PROGRAM SERVICES CONDUCT MEDICAL RESEARCH, IDENTIFY MEDICAL RESEARCH PARTNERS 52277 SOUTH AMERICA 0 0 PROGRAM SERVICES CONDUCT MEDICAL RESEARCH, IDENTIFY MEDICAL RESEARCH PARTNERS 3835 SOUTH ASIA 0 0 PROGRAM SERVICES CONDUCT MEDICAL RESEARCH, IDENTIFY MEDICAL RESEARCH PARTNERS 84765 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CONDUCT MED RESEARCH, IDENTIFY MED RESEARCH PARTNERS, BEGIN CLINICAL TRIALS 308717 0 0 0 0 0 0 3619047 0 3619047 0 0 0 0 0 0 PART III ACCOUNTING METHOD: X X 1 1 X X X 1 0 0 0 0 0 0 0 0 SUSAN DESMOND-HELLMANN DIRECTOR 0 1203084 0 132188 0 126420 0 42000 0 25612 0 1529304 0 0 TREVOR MUNDEL DIRECTOR, BOARD CHAIR 0 1043138 0 0 0 46563 0 42000 0 36684 0 1168385 0 0 HELENE MADONICK DIRECTOR 0 370678 0 0 0 362373 0 42000 0 34323 0 809374 0 0 EMILIO EMINI DIRECTOR 0 517527 0 138 0 23908 0 42000 0 23986 0 607559 0 0 ANDREW FARNUM DIRECTOR 0 399398 0 15000 0 2396 0 42000 0 14530 0 473324 0 0 PENNY HEATON CHIEF EXECUTIVE OFFICER 684615 0 75000 0 13853 0 42000 0 23887 0 839355 0 0 0 HELEN BOUDREAU END 812019 SECRETARY & TREASURER 220673 0 50000 0 214232 0 40601 0 19652 0 545158 0 0 0 MARY THISTLE START 812019 TREASURER 390331 0 50000 0 14453 0 42000 0 23568 0 520352 0 0 0 SALLY JENNINGS START 812019 SECRETARY 364985 0 42500 0 5758 0 42000 0 36097 0 491340 0 0 0 DAVID KAUFMAN HEAD OF TRANSLATIONAL DEVELOPMENT 557616 0 0 0 8708 0 42000 0 34335 0 642659 0 0 0 JORG THOMMES HEAD OF CHEM, MFG & CONTROLS 385262 0 50000 0 10982 0 42000 0 34224 0 522468 0 0 0 DINA BERDIEVA HEAD OF PROJ. MGMT. & CLIN 378665 0 50000 0 0 0 42000 0 41842 0 512507 0 0 0 JARED SILVERMAN HEAD OF TRANSLATIONAL DISCOVERY 366154 0 40000 0 8974 0 42000 0 36557 0 493685 0 0 0 TARYN ROGALSKI-SALTER HEAD OF REGULATORY AFFAIRS 385262 0 50000 0 33049 0 42000 0 26207 0 536518 0 0 0 JEFFREY BARRET HEAD OF QUANT. SCIENCES 395400 0 50000 0 10923 0 42000 0 34224 0 532547 0 0 0 ALEXANDER SCHMIDT CLINICAL DEVELOPMENT LEADER 380192 0 45000 0 5374 0 42000 0 36692 0 509258 0 0 0 RUSSELL WEINER BIOMARKER ASSAY DEVELOPMENT LEADER 354846 0 40000 0 43385 0 42000 0 24387 0 504618 0 0 0 DEBRA WEISS HEAD OF QUALITY ASSURANCE 380192 0 45000 0 2114 0 42000 0 27484 0 496790 0 0 0 PART I, LINE 1A THE TRAVEL POLICY, APPLICABLE TO ALL EMPLOYEES, ALLOWS FOR FIRST-CLASS AIR TRAVEL ON DOMESTIC RED-EYE FLIGHTS DEPARTING AFTER 9:00 PM THAT EXCEED FIVE HOURS IN DURATION. RELOCATION PACKAGES ARE GENERALLY PROVIDED TO NEW EMPLOYEES WHO RESIDE MORE THAN 50 MILES OUTSIDE OF CAMBRIDGE, MASSACHUSSETTS. THE ORGANIZATION GROSSES UP TAXABLE RELOCATION BENEFITS PART I, LINE 4A HELEN BOUDREAU $212,500 FORM 990, PART VI, SECTION A, LINE 2 SUSAN DESMOND-HELLMANN, TREVOR MUNDEL, ANDREW FARNUM, EMILIO EMINI, AND HELENE MADONICK HAVE A BUSINESS RELATIONSHIP AS EMPLOYEES OF THE BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOLE MEMBER OF BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE IS BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 7A BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE, HAS THE AUTHORITY TO APPOINT AND REMOVE DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE, HAS THE AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE, LEASE, OR EXCHANGE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF THE ORGANIZATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ORGANIZATION AND ADOPTION OF A PLAN FOR THE DISTRIBUTION OF THE ASSETS OF THE ORGANIZATION, IN ACCORDANCE WITH THE ORGANIZATION'S ORGANIZATIONAL DOCUMENTS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY A THIRD-PARTY ACCOUNTANT. AFTER PREPARATION, IT IS REVIEWED IN DETAIL BY THE TREASURER OF THE INSTITUTE, AND THE TAX TEAM AND CONTROLLER OF BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE. A COPY OF THE FORM 990 IS PROVIDED TO THE ENTIRE BOARD PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE CONSIDERED "COVERED PERSONS" FOR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, AND AS SUCH, ARE REQUIRED TO ANNUALLY DISCLOSE ANY RELATIONSHIPS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST INVOLVING THE ORGANIZATION. IN ADDITION, ANY TRANSACTIONS BETWEEN THE ORGANIZATION AND ANY OF THESE INDIVIDUALS (OR THEIR FAMILY MEMBERS OR AN AFFILIATED ENTITY) MUST BE DISCLOSED TO THE SECRETARY. IF THE SECRETARY HAS A POTENTIAL CONFLICT OF INTEREST, IT MUST BE DISCLOSED TO THE CHIEF EXECUTIVE OFFICER. THE SECRETARY AND CHIEF EXECUTIVE OFFICER ARE RESPONSIBLE FOR REVIEWING THE ANNUAL CONFLICT OF INTEREST DISCLOSURES AND RESOLVING ANY POTENTIAL CONFLICT OF INTERESTS THAT MAY ARISE. THE COVERED PERSON IS REQUIRED TO REFRAIN FROM USING HIS OR HER PERSONAL INFLUENCE TO ENCOURAGE THE ORGANIZATION TO ENTER INTO THE COVERED TRANSACTION. ADDITIONALLY, HE OR SHE MUST NOT PARTICIPATE IN ANY DISCUSSIONS REGARDING THE COVERED TRANSACTIONS WITH OFFICERS, DIRECTORS AND EMPLOYEES OF THE ORGANIZATION, EXCEPT TO RESPOND TO REQUESTS FOR INFORMATION. IF THE TRANSACTION IS DEEMED TO BE REASONABLE BY THE DISINTERESTED DIRECTORS (IN THE CASE OF A CONFLICT INVOLVING A DIRECTOR OR THE CHIEF EXECUTIVE OFFICER) OR CHIEF EXECUTIVE OFFICER (IN THE CASE OF A CONFLICT INVOLVING ANOTHER OFFICER OR KEY EMPLOYEE), THE ORGANIZATION MAY ENTER INTO THE TRANSACTION, AS LONG AS IT IS FAIR AND REASONABLE TO THE ORGANIZATION. IN SEPTEMBER 2019, THE ORGANIZATION REVISED ITS CONFLICT OF INTEREST POLICY AS FOLLOWS: THE POLICY WAS EXPANDED TO INCLUDE ALL EMPLOYEES. SIMILAR TO THE COVERED PERSONS, EMPLOYEES ARE REQUIRED TO COMPLETE A CONFLICT OF INTEREST CERTIFICATION UPON COMMENCING EMPLOYMENT AND TO UPDATE THE CERTIFICATION ANNUALLY, AND AT ANY TIME THERE IS A CHANGE THAT REQUIRES DISCLOSURE. THE HEAD OF COMPLIANCE & RISK MANAGEMENT IS NOW RESPONSIBLE FOR REVIEWING THE CERTIFICATIONS AND ADMINISTERING AND MAINTAINING THE POLICY. THE UPDATED POLICY RETAINS THAT IF AN OFFICER, DIRECTOR, OR MEMBER OF SENIOR LEADERSHIP BECOMES AWARE OF A TRANSACTION THAT COULD CAUSE A CONFLICT OF INTEREST, THEY ARE TO IMMEDIATELY DISCLOSE SUCH TO THE SECRETARY OF THE ORGANIZATION. PROCEDURES FOR RESOLVING A COVERED TRANSACTION AFTER DISCLOSURE TO THE SECRETARY REMAIN IN PLACE AS OUTLINED ABOVE. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF THE BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE USES AN INDEPENDENT REVIEW, COMPARABILITY DATA AND CONTEMPORANEOUS SUBSTANTIATION TO ESTABLISH TOTAL REMUNERATION PACKAGES FOR THE CEO, OFFICERS, AND CERTAIN KEY EMPLOYEES. THE BOARD IS PRESENTED WITH STUDY DATA, REVIEWS IT TO DETERMINE REASONABLENESS, AND THEN APPROVES TOTAL REMUNERATION ACCORDINGLY. ALL SUCH OFFICER AND CERTAIN KEY EMPLOYEE TOTAL REMUNERATION PACKAGES ARE REVIEWED AND APPROVED BY THE BOARD ANNUALLY. THE MOST RECENT COMPENSATION STUDY FOR PURPOSES OF THIS COMPENSATION PERIOD WAS CONDUCTED BY AN INDEPENDENT CONSULTANT IN 2019. COMPARABILITY DATA IS ALSO USED TO ESTABLISH COMPENSATION PACKAGES FOR OTHER EMPLOYEES. COMPENSATION PACKAGES FOR OTHER EMPLOYEES ARE APPROVED BY THE CEO ANNUALLY, BASED ON A COMPENSATION PHILOSOPHY ORIGINALLY APPROVED BY THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE'S FINANCIAL STATEMENTS ARE CONSOLIDATED WITH BILL & MELINDA GATES FOUNDATION, AND THE CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE AT WWW.GATESFOUNDATION.ORG. FORM 990, PART VI, SECTION A, LINE 9: ANY OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE THAT IS AN EMPLOYEE OF THE BILL & MELINDA GATES FOUNDATION CAN BE REACHED AT THE FOLLOWING ADDRESS. FOR 2019, THIS INCLUDES SUSAN DESMOND-HELLMANN, TREVOR MUNDEL, EMILIO EMINI, HELENE MADONICK AND ANDREW FARNUM: P.O. BOX 23350 SEATTLE, WA 98102 FORM 990, PART IX, LINE 11G OTHER FEES FOR SERVICES: PROGRAM SERVICE EXPENSES 3,249,317. MANAGEMENT AND GENERAL EXPENSES 20,330. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 3,269,647. SCIENTIFIC CONSULTING AND TECHNICAL ASSISTANCE: PROGRAM SERVICE EXPENSES 5,360,481. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,360,481. RECRUITING AND PUBLIC RELATIONS: PROGRAM SERVICE EXPENSES 328,674. MANAGEMENT AND GENERAL EXPENSES 330,010. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 658,684. OPERATIONAL ASSISTANCE: PROGRAM SERVICE EXPENSES 8,909. MANAGEMENT AND GENERAL EXPENSES 733,839. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 742,748. BILL & MELINDA GATES FOUNDATION (BMGF) PO BOX 23350 SEATTLE WA 98102 562618866 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 GATES PHILANTHROPY PARTNERS PO BOX 23350 SEATTLE WA 98102 473290897 GRANTMAKING PUBLIC CHARITY WA 501(C)(3) LINE 7 BILL & MELINDA GATES FOUNDATION (BMGF) 1 BILL & MELINDA GATES FOUNDATION TRUST (BMGFT) PO BOX 23350 SEATTLE WA 98102 911663695 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 ACCELERATOR GPS SIDE CAR FUND LP PO BOX 13329 RESEARCH TRIANGLE PARK NC 27709 814667411 PROGRAM RELATED INVESTMENT OF BMGF DE N/A GREENBRIAR AS HOLDINGS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208908 INVESTMENT OF BMGFT CJ N/A GREENBRIAR EQUITY FUND II-A LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 260438001 INVESTMENT OF BMGFT DE N/A GREENBRIAR EQUITY FUND III AIV MM NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 811112433 INVESTMENT OF BMGFT DE N/A GREENBRIAR EQUITY FUND III AIV NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208417 INVESTMENT OF BMGFT CJ N/A GREENBRIAR EQUITY FUND III AIV SK NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 473805287 INVESTMENT OF BMGFT DE N/A GREENBRIAR EQUITY FUND III-A AIV WFCI LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981219020 INVESTMENT OF BMGFT CJ N/A GREENBRIAR EQUITY FUND III-A LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 461543216 INVESTMENT OF BMGFT DE N/A THE GLOBAL GOOD FUND I LLC 3150 139TH AVE SE BELLEVUE WA 98005 272796838 INVESTMENT OF BMGFT DE N/A AFRICAN AGRICULTURAL CAPITAL FUND LLC 6TH FLOOR TOWER A 1 CYBERCITY EBENE MP 981017696 PROGRAM RELATED INVESTMENT OF BMGF MP N/A C 1 GREENBRIAR AS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208754 INVESTMENT OF BMGFT CJ N/A C 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0